Article
MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism
6 Apr 2011
Abstract excerpt
Oncolytic measles viruses (MV) derived from the live attenuated vaccine strain have been engineered for increased tumor-cell specificity, and are currently under investigation in clinical trials including a phase I study for glioblastoma multiforme (GBM). Recent preclinical studies have shown that the cellular tropism of several viruses can be controlled by inserting microRNA-target sequences into their genomes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
